SEC Company Response from ORAMED PHARMACEUTICALS INC. (ORMP) (CIK 0001176309) (ORMP) — Feb 9, 2021
ORAMED PHARMACEUTICALS INC. (ORMP) (CIK 0001176309)
Date: Feb. 9, 2021 · CIK: 0001176309 · Accession: 0001213900-21-007712
AI Filing Summary & Sentiment
File numbers found in text: 333-252696
Letter
VIA EDGAR Division of Corporation Finance United States Securities and Exchange Commission Washington, D.C. 20549 Registration Statement on Form S-3 File No. 333-252696
Re: Oramed Pharmaceuticals Inc.
Dear Sir or Madam:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Oramed Pharmaceuticals Inc. (the “Registrant”) hereby requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 9:00 a.m., Eastern Time, on February 10, 2021, or as soon as practicable thereafter.
The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Oded Har-Even of Sullivan & Worcester LLP at (212) 660-5002 and that such effectiveness also be confirmed in writing.
Very truly yours,
Oramed Pharmaceuticals Inc.
Show Raw Text
CORRESP
1
filename1.htm
February 9, 2021
VIA EDGAR
Ada D. Sarmento
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Re:
Oramed Pharmaceuticals Inc.
Registration Statement on Form S-3
File No. 333-252696
Dear Sir or Madam:
Pursuant to Rule 461
under the Securities Act of 1933, as amended, Oramed Pharmaceuticals Inc. (the “Registrant”) hereby requests that the
effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 9:00 a.m.,
Eastern Time, on February 10, 2021, or as soon as practicable thereafter.
The Registrant respectfully
requests that it be notified of such effectiveness by a telephone call to Oded Har-Even of Sullivan & Worcester LLP at (212)
660-5002 and that such effectiveness also be confirmed in writing.
Very truly yours,
Oramed Pharmaceuticals Inc.
By:
/s/ Avraham Gabay
Name:
Avraham Gabay
Title:
Chief Financial Officer